论文部分内容阅读
作者用放射免疫法测定宫颈癌患者的血清铁蛋白水平。研究血清铁蛋白水平与宫颈癌预后之间的关系。各期宫颈癌患者共98例。于初诊时测定血清铁蛋白水平1次,以后在治疗中及治疗后作定期的测定。并以52例无宫颈癌妇女作为对照,其结果如下:在对照组平均血清铁蛋白为34ng/ml,上限为108ng/ml(第98百分位数)。年龄较大的妇女(51岁以上)比年轻妇女的平均水平略高,但无统计学意义。有宫颈癌组,血清铁蛋白水平的升高与宫颈癌期别的发展成正比(Ⅳ期除外)。第Ⅱ-Ⅳ期的病例,铁蛋白平均分别为142.9ng/ml,237.9ng/ml及290.5ng/ml,明显地高于对照组的病例。本文98例宫颈癌患者测定结果如下:50例(51%)血清铁蛋白高于正常;其中16例原位癌中的1例,14例Ⅰ期癌中的3例、31例Ⅱ期癌中的16例、28例Ⅲ期癌中的23例、9例Ⅳ期癌中的7例其
The authors used radioimmunoassay in patients with cervical cancer serum ferritin levels. To study the relationship between serum ferritin level and the prognosis of cervical cancer. A total of 98 cases of cervical cancer patients. Serum ferritin level was determined at the first visit and then periodically after treatment and after treatment. 52 women without cervical cancer as control, the results are as follows: in the control group average serum ferritin was 34ng / ml, the upper limit of 108ng / ml (98th percentile). Older women (51 and older) have slightly higher average levels than younger women, but not statistically significant. Cervical cancer group, elevated serum ferritin levels and cervical cancer is proportional to the development of the other (except in stage IV). In the cases of stage II-IV, the average ferritin levels were 142.9ng / ml, 237.9ng / ml and 290.5ng / ml, respectively, which were significantly higher than those in the control group. In this paper, 98 cases of cervical cancer patients were determined as follows: 50 cases (51%) serum ferritin higher than normal; of which 16 cases of carcinoma in situ in 1 case, 14 cases of stage Ⅰ cancer in 3 cases, 31 cases of stage Ⅱ cancer Of 16 cases, 28 cases of stage Ⅲ cancer in 23 cases, 9 cases of stage Ⅳ cancer in 7 cases